These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19666628)

  • 1. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use.
    Gorski T; Cadore EL; Pinto SS; da Silva EM; Correa CS; Beltrami FG; Kruel LF
    Br J Sports Med; 2011 Feb; 45(2):85-90. PubMed ID: 19666628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A temporal model for nonelite triathlon race injuries.
    Rimmer T; Coniglione T
    Clin J Sport Med; 2012 May; 22(3):249-53. PubMed ID: 22430328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of injuries in long-distance triathletes.
    Egermann M; Brocai D; Lill CA; Schmitt H
    Int J Sports Med; 2003 May; 24(4):271-6. PubMed ID: 12784169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID use increases the risk of developing hyponatremia during an Ironman triathlon.
    Wharam PC; Speedy DB; Noakes TD; Thompson JM; Reid SA; Holtzhausen LM
    Med Sci Sports Exerc; 2006 Apr; 38(4):618-22. PubMed ID: 16679974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in ultra-triathlon performance at increasing race distance.
    Rüst CA; Knechtle B; Knechtle P; Rosemann T; Lepers R
    Percept Mot Skills; 2013 Apr; 116(2):690-706. PubMed ID: 24032340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium supplementation is not required to maintain serum sodium concentrations during an Ironman triathlon.
    Hew-Butler TD; Sharwood K; Collins M; Speedy D; Noakes T
    Br J Sports Med; 2006 Mar; 40(3):255-9. PubMed ID: 16505084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health professionals' perceptions of musculoskeletal injury and injury risk factors in Australian triathletes: a factor analysis.
    Gosling CM; Forbes AB; Gabbe BJ
    Phys Ther Sport; 2013 Nov; 14(4):207-12. PubMed ID: 23177357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and gender interactions in short distance triathlon performance.
    Etter F; Knechtle B; Bukowski A; Rüst CA; Rosemann T; Lepers R
    J Sports Sci; 2013; 31(9):996-1006. PubMed ID: 23356412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profile of injuries in athletes seeking treatment during a triathlon race series.
    Gosling CM; Forbes AB; McGivern J; Gabbe BJ
    Am J Sports Med; 2010 May; 38(5):1007-14. PubMed ID: 20436054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of training volume and experience on amateur Ironman triathlon performance.
    Sinisgalli R; de Lira CAB; Vancini RL; Puccinelli PJG; Hill L; Knechtle B; Nikolaidis PT; Andrade MS
    Physiol Behav; 2021 Apr; 232():113344. PubMed ID: 33516745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of exercise-associated hyponatremia in male ultraendurance athletes.
    Knechtle B; Gnädinger M; Knechtle P; Imoberdorf R; Kohler G; Ballmer P; Rosemann T; Senn O
    Clin J Sport Med; 2011 May; 21(3):226-32. PubMed ID: 21427567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric profiles of elite older triathletes in the Ironman Brazil compared with those of young Portuguese triathletes and older Brazilians.
    Silva DA; Benedetti TR; Ferrari EP; Meurer ST; Antes DL; Silva AM; Santos DA; Matias CN; Sardinha LB; Vieira F; Petroski EL
    J Sports Sci; 2012; 30(5):479-84. PubMed ID: 22260093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral non-steroidal anti-inflammatory drug use in recreational runners participating in Parkrun UK: Prevalence of use and awareness of risk.
    Rosenbloom CJ; Morley FL; Ahmed I; Cox AR
    Int J Pharm Pract; 2020 Dec; 28(6):561-568. PubMed ID: 32567142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use, knowledge, and behaviors around their use and misuse in Irish collegiate student-athletes.
    O'Connor S; McCaffrey N; Whyte E; Moran K; Lacey P
    Phys Sportsmed; 2019 Sep; 47(3):318-322. PubMed ID: 30479177
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic use of NSAIDs by athletes: a risk/benefit assessment.
    Warden SJ
    Phys Sportsmed; 2010 Apr; 38(1):132-8. PubMed ID: 20424410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.
    Delcò F; Michetti P; Beglinger C; Fried M; Szucs TD
    Digestion; 2004; 69(1):10-9. PubMed ID: 14755148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition and performance: anxiety, mood and perceived exertion among Ironman triathletes.
    Parry D; Chinnasamy C; Papadopoulou E; Noakes T; Micklewright D
    Br J Sports Med; 2011 Nov; 45(14):1088-94. PubMed ID: 20542977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run.
    Page AJ; Reid SA; Speedy DB; Mulligan GP; Thompson J
    Clin J Sport Med; 2007 Jan; 17(1):43-8. PubMed ID: 17304005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Contributions of Swimming, Cycling, and Running Performances on Overall Triathlon Performance Over a 26-Year Period.
    Figueiredo P; Marques EA; Lepers R
    J Strength Cond Res; 2016 Sep; 30(9):2406-15. PubMed ID: 26808853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.